The guidelines are intended to identify significant financial interests of network-affiliated researchers and avoid conflicts of interest, or the appearance of such conflicts, in activities of the networks. Network Leaders approved the guidelines on the April 2010 Network Leaders call and the document has been adopted as standard operating procedure for all networks effective April 15, 2010.
NIAID HIV/AIDS Clinical Trials Networks Financial Disclosure and COI Guidelines SOP
Version 10.0 of the “NIAID (DAIDS)-supported and/or Sponsored HIV/AIDS Clinical Trials Networks Financial Disclosure and Conflict of Interest Guidelines”.
Last updated May 4, 2021
Additional financial disclosure guidance for investigators can be found at the following sources:
National Institutes of Health (NIH) FDCOI Guidance
Food and Drug Administration (FDA) FDCOI Guidance